Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 13, 2017

View Archived Issues

Ionis Pharmaceuticals licenses drug to Dynacure

EMA's CHMP supports expanding Nplate indication

Preclinical evaluation of selective ATM kinase AZD-1390 inhibitor for treatment of glioblastoma

EMA committee recommends expanding approval of Orkambi

Discovery of novel ERK1/2 inhibitors with robust antitumor activity in vivo

CHMP issues positive opinion on Avastin biosimilar ABP-215

Neurimmune, Ono Pharmaceutical to collaborate on antibodies for neurodegenerative diseases

Devonian Health Group begins phase IIa study of Thykamine in atopic dermatitis

Benralizumab obtains positive opinion in E.U.

FDA accepts for review Sunovion's NDA for dasotraline

EMA committee confirms refusal of Fanaptum MAA

CFTR potentiator GLPG-2451 appears safe in first-in-human study

FDA expands approval of Bristol-Myers Squibb's Sprycel

Phase III results reported for ozanimod in relapsing MS

EMA grants PRIME designation to Mereo's BPS-804

Pfizer initiates phase I study of pegfilgrastim biosimilar PF-06881894

Wound healing improved with SNF-472 in hemodialysis patients with calciphylaxis

PharmaMar expects negative feedback for Aplidin MAA from EMA committee

University of Massachusetts divulges rAAV vectors encoding aspartoacylase

Novel Bcl-2-targeting drugs created at BioVentures

Dana-Farber Cancer Institute presents new anti-EGFR proteolysis-targeting chimera compounds

Baruch S. Blumberg Institute identifies novel glucosidase inhibitors

Five Prime, GlaxoSmithKline present novel neighbor of punc e11 polypeptides

Actelion studies ACT-709478 in patients with photosensitive epilepsy

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 9, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...